Clinical trials in the time of COVID: Risks, mitigation and lessons learned
Stephanie Finnegan, COO of Cromos Pharma explores some of the major disruptions caused by the ongoing pandemic to clinical trials processes. In this presentation she looks at risks, how to mitigate crisis management, and what the sector has learned since being forced into some major changes due to COVID-19.
This presentation was prepared January 2021 for activities around JP Morgan Healthcare Week. Please feel free to share this presentation with colleagues. If you have any queries please contact: inquiry@cromospharma.com.
